SNP data from blood DNAs of patients with gastric cancer

ABSTRACT: The identification of surrogate single nucleotide polymorphism (SNP) markers that can predict responses to chemotherapy could enable the efficient selection of patients for various regimens. Genome-wide association studies in clinical populations are theoretically capable of identifying markers that are capable of influencing drug responses. We used Affymetrix’s SNP Array 6.0 to detail genetic polymorphism of patient’s group showing differential responsiveness to various regimens and profiled SNP biomarkers for various regimens.

ORGANISM(S): Homo sapiens

PROVIDER: GSE26853 | GEO | 2011/12/31

SECONDARY ACCESSION(S): PRJNA135977

REPOSITORIES: GEO